2X Oncology Inc. expands U.S. Executive Team, names George O. Elston as CEO
Hoersholm, Denmark, April 6th, 2017 – Oncology Venture Sweden AB (OV.ST) today announced that its Board of Directors has appointed veteran life science executive George O. Elston as its CEO (Chief Executive Officer) of 2X Oncology Inc. (2X) a privately-owned spinout of Oncology Venture that develops precision medicine for Women’s Cancers. Currently 92% of 2X Oncology is owned by Oncology Venture. Dr. Marie Foegh who has carried the role as CEO and CMO (Chief Medical Officer) since January 2017 will continue as CMO. Mr. Elston is also appointed to the Company’s Board of Directors. Elston will